Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Genomic and immune profiling of breast cancer brain metastases

12 May 2025

Abstract excerpt

BACKGROUND: Brain metastases (BrM) arising from breast cancer (BC) are an increasing consequence of advanced disease, with up to half of patients with metastatic HER2 + or triple negative BC experiencing central nervous system (CNS) recurrence. The genomic alterations driving CNS recurrence, along with contributions of the immune microenvironment, particularly by intrinsic subtype, remain unclear. METHODS: We...

Topics

Join the communities discussing this publication.

Brain Metastases and Treatment
Cancer Genomics and Diagnostics
Lung Cancer Research Studies

Source

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Identifiers

PMID: 40355907
DOI: 10.1186/s40478-025-02001-3

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 1 Sept 2026.

Community interpretation

Discuss the evidence

Ask a question, add context or challenge an interpretation. Community activity is separate from scientific evidence strength.

0

discussions

0

replies

Citations encouraged

Claims remain attributable.

No discussion yet

Be the first to add a careful, cited interpretation.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Genomic and immune profiling of breast cancer brain metastasesPMID 40355907Read ↗

Identification of targetable genomic profiling of breast cancer brain metastases identifies alterations and genomic signatures relevant to immune-checkpoint and PARP inhibitorsSemantic proximity Read ↗

Breast cancer brain metastases genomic profiling identifies alterations targetable by immune-checkpoint and PARP inhibitorsSemantic proximity Read ↗

Gene expression profiling in a retrospective real-world cohort of breast cancer brain metastases and paired primary tumors identifies biological changes with potential therapeutic implicationsSemantic proximity Read ↗

Comprehensive molecular biomarker identification in breast cancer brain metastases.Semantic proximity Read ↗

Targetable genomic profiling of breast cancer brain metastases identifies alterations and genomic signatures relevant to immune-checkpoint and PARP inhibitorsSemantic proximity Read ↗

Genomics of breast cancer brain metastases: a meta-analysis and therapeutic implicationsSemantic proximity Read ↗

Intrinsic Subtype Switching and Acquired ERBB2/HER2 Amplifications and Mutations in Breast Cancer Brain Metastases.Semantic proximity Read ↗

The genomic landscape of breast cancer brain metastases: a systematic review.Semantic proximity Read ↗

Identification of Breast Cancer Immune Subtypes by Analyzing Bulk Tumor and Single Cell TranscriptomesSemantic proximity Read ↗

Integrated Genomic and Epigenomic Analysis of Breast Cancer Brain MetastasisSemantic proximity Read ↗

Metastatic breast cancers have reduced immune cell recruitment but harbor increased macrophages relative to their matched primary tumorsSemantic proximity Read ↗

Integrated genomic and transcriptomic analysis of human brain metastases identifies alterations of potential clinical significance.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.